Cell Signaling Technology

WSTF Antibody

#2152 · $317

200
Citing papers
355.7k
Combined citations
Supplier page Find this product

Research areas

Global Cancer Incidence and Screening7Diabetes, Cardiovascular Risks, and Lipoproteins6Lipoproteins and Cardiovascular Health6Genomics and Phylogenetic Studies6Advancements in Battery Materials5Diabetes Management and Research5Autism Spectrum Disorder Research5Health Systems, Economic Evaluations, Quality of Life5

Papers citing this product

1
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
CA A Cancer Journal for Clinicians·2024·22.1k cit.·DOI
2
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
The Lancet·2018·14k cit.·DOI
3
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
New England Journal of Medicine·2015·11.9k cit.·DOI
4
2018 ESC/ESH Guidelines for the management of arterial hypertension
European Heart Journal·2018·10.4k cit.·DOI
5
A Randomized Trial of Intraarterial Treatment for Acute Ischemic Stroke
New England Journal of Medicine·2014·6.6k cit.·DOI
6
2016 European Guidelines on cardiovascular disease prevention in clinical practice
European Heart Journal·2016·6.5k cit.·DOI
7
30 Years of Lithium‐Ion Batteries
Advanced Materials·2018·5.9k cit.·DOI
8
The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) Statement
PLoS Medicine·2015·5.2k cit.·DOI
9
Dapagliflozin in Patients with Chronic Kidney Disease
New England Journal of Medicine·2020·5.1k cit.·DOI
10
Colorectal cancer
The Lancet·2019·4.9k cit.·DOI
WSTF Antibody — Evidence — PubIndex